Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,196 | 377 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,349 | 58 | $0 (2024) |
| Amgen Inc. | $938.01 | 49 | $0 (2024) |
| PFIZER INC. | $522.38 | 38 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $504.61 | 19 | $0 (2023) |
| GlaxoSmithKline, LLC. | $500.27 | 24 | $0 (2023) |
| Amarin Pharma Inc. | $401.60 | 21 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $309.11 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $274.25 | 17 | $0 (2024) |
| CSL Behring | $271.66 | 11 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $249.98 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,472 | 88 | Amgen Inc. ($358.70) |
| 2023 | $1,848 | 89 | AstraZeneca Pharmaceuticals LP ($428.79) |
| 2022 | $1,899 | 83 | AstraZeneca Pharmaceuticals LP ($434.80) |
| 2021 | $1,977 | 117 | Amarin Pharma Inc. ($401.60) |
All Payment Transactions
377 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.41 | General |
| 12/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Cardiology | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.41 | General |
| 11/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: Cardiology | ||||||
| 10/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Obesity | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.47 | General |
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Cardiology | ||||||
| 10/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/01/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Genetic Disease | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.47 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 530 | 582 | $109,884 | $31,084 |
| 2021 | 3 | 303 | 323 | $56,745 | $13,323 |
| 2020 | 3 | 626 | 719 | $133,443 | $28,201 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 282 | 318 | $83,634 | $26,143 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 54 | $9,450 | $2,964 | 31.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 194 | 210 | $16,800 | $1,977 | 11.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 139 | 145 | $38,135 | $10,241 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 46 | $8,050 | $2,013 | 25.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 121 | 132 | $10,560 | $1,069 | 10.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 330 | 391 | $102,833 | $23,346 | 22.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 252 | 282 | $22,560 | $2,714 | 12.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 46 | $8,050 | $2,140 | 26.6% |
About Christopher Vela, PAC
Christopher Vela, PAC is a Physician Assistant healthcare provider based in Midland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2011. The National Provider Identifier (NPI) number assigned to this provider is 1366728909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Vela, PAC has received a total of $7,196 in payments from pharmaceutical and medical device companies, with $1,472 received in 2024. These payments were reported across 377 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,196).
As a Medicare-enrolled provider, Vela has provided services to 1,459 Medicare beneficiaries, totaling 1,624 services with total Medicare billing of $72,607. Data is available for 3 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Midland, TX
- Active Since 10/27/2011
- Last Updated 08/11/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1366728909
Products in Payments
- Repatha (Biological) $875.87
- CUVITRU (Biological) $485.57
- Vascepa (Drug) $401.60
- DUPIXENT (Biological) $399.05
- FARXIGA (Drug) $384.09
- TEZSPIRE (Biological) $374.83
- ELIQUIS (Drug) $362.91
- NUCALA (Biological) $357.57
- JARDIANCE (Drug) $302.87
- BREZTRI (Drug) $285.45
- Hizentra (Biological) $271.66
- VERQUVO (Drug) $243.53
- LifeVest (Device) $232.56
- XARELTO (Drug) $156.82
- VYNDAQEL (Drug) $154.54
- Xembify (Biological) $146.60
- LOKELMA (Drug) $126.97
- TRELEGY ELLIPTA (Drug) $120.78
- Yupelri (Drug) $112.57
- FASENRA (Biological) $111.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Midland
Samuel Baumguardner, Pa-C, PA-C
Physician Assistant — Payments: $14,403
Mrs. Pamela Foster, Pa, PA
Physician Assistant — Payments: $12,205
Salwa Mohamedaman
Physician Assistant — Payments: $8,438
Alison Smith, Pa, PA
Physician Assistant — Payments: $7,100
Stephanie Johnson
Physician Assistant — Payments: $7,043
Pamela Doughty
Physician Assistant — Payments: $6,115